Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMISĀ® T-cell therapies to treat cancers and autoimmune diseases. The company focuses on B-cell malignancies and is exploring applications in solid tumors.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.